{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Molecular docking", "Pentavalent antimonial", "Promastigote", "Visceral leishmaniasis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35299910", "DateRevised": {"Year": "2023", "Month": "03", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1007/s12639-021-01441-7"], "Journal": {"ISSN": "0971-7196", "JournalIssue": {"Volume": "46", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Mar"}}, "Title": "Journal of parasitic diseases : official organ of the Indian Society for Parasitology", "ISOAbbreviation": "J Parasit Dis"}, "ArticleTitle": "Screening of medicinal plants unraveled the leishmanicidal credibility of <i>Garcinia cowa</i>; highlighting Norcowanin, a novel anti-leishmanial phytochemical through in-silico study.", "Pagination": {"StartPage": "202", "EndPage": "214", "MedlinePgn": "202-214"}, "Abstract": {"AbstractText": ["Leishmaniasis, one of the most prevalent yet neglected parasitic causes of death, yearns for therapeutic control and treatment. Severely toxic and inefficient modern-day pentavalent antimonials, caters the search for naturally derived drugs, as efficient alternatives for disease treatment. The anti-promastigote activity of ten different plants selected for their ethnomedicinal properties revealed significant leishmanicidal capacity; the most potent being <i>Garcinia cowa</i> methanolic extract with an IC<sub>50</sub> value of 21.4\u00a0\u00b5g/ml. <i>Garcinia cowa,</i> a plant endemic to North-Eastern India that is of the Clusiaceae family, is replete with such medicinal qualities as antimicrobial, antiviral, antiparasitic, and antiproliferative activities. Computational biology with its tools such as molecular docking has opened new horizons aimed at a better understanding of biological systems, complexes, and their interactions, and subsequently drug discovery via in silico techniques. Therefore, an <i>in-silico</i> study was designed to evaluate the binding capability of six phytochemicals- cowanin, cowanol, cowaxanthone, norcowanin, rubraxanthone, and a basic xanthone, found in <i>Garcinia cowa</i> against Pentamidine, a synthetic anti-leishmanial drug. The active sites of three characteristic enzymes belonging to the <i>Leishmania donovani</i> parasite: O-acetylserine sulfhydrylase (OASS), Trypanothione reductase (TryR), and N-Myristoyltransferase (NMT) were chosen as target proteins. Results revealed lower binding energies and higher affinities, of nearly all the phytochemicals with respect to Pentamidine, indicating their leishmanicidal potential. Norcowanin showed the lowest average binding of -\u20099.8\u00a0kcal/mol against all the three enzymes under study."], "CopyrightInformation": "\u00a9 Indian Society for Parasitology 2021."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.59056.3f", "0000 0001 0664 9773"], "Affiliation": "Laboratory of Cell and Molecular Biology, Department of Botany, Centre of Advanced Study, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, 700019 India."}], "LastName": "Pyne", "ForeName": "Nibedita", "Initials": "N"}, {"Identifier": ["0000-0002-5295-6499"], "AffiliationInfo": [{"Identifier": ["grid.59056.3f", "0000 0001 0664 9773"], "Affiliation": "Laboratory of Cell and Molecular Biology, Department of Botany, Centre of Advanced Study, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, 700019 India."}], "LastName": "Paul", "ForeName": "Santanu", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "J Parasit Dis", "NlmUniqueID": "9713059", "ISSNLinking": "0971-7196"}, "CoiStatement": "Conflict of interestThe authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Angiulli G, Lantella A, Forte E, et al. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH: O2 oxidoreductase activity shared by glutathione reductase. Biochim Biophys Acta Gen Subj. 2015;1850:1891\u20131897. doi: 10.1016/j.bbagen.2015.05.022.", "ArticleIdList": ["10.1016/j.bbagen.2015.05.022", "26033467"]}, {"Citation": "Arenas R, Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J. Leishmaniasis: a review. RF1000Research. 2017;6:1\u201315. doi: 10.12688/f1000research.11120.1.", "ArticleIdList": ["10.12688/f1000research.11120.1", "PMC5464238", "28649370"]}, {"Citation": "Ariyanayagam MR, Fairlamb AH. Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol Biochem Parasitol. 2001;115:189\u2013198. doi: 10.1016/S0166-6851(01)00285-7.", "ArticleIdList": ["10.1016/S0166-6851(01)00285-7", "11420105"]}, {"Citation": "Brannigan JA, Smith BA, Yu Z, et al. N-myristoyltransferase from Leishmania donovani: structural and functional characterization of a potential drug target for visceral leishmaniasis. J Mol Biol. 2010;396:985\u2013999. doi: 10.1016/j.jmb.2009.12.032.", "ArticleIdList": ["10.1016/j.jmb.2009.12.032", "PMC2829124", "20036251"]}, {"Citation": "Baiocco P, Ilari A, Ceci P, et al. Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation. ACS Med Chem Lett. 2011;2:230\u2013233. doi: 10.1021/ml1002629.", "ArticleIdList": ["10.1021/ml1002629", "PMC4017975", "24900299"]}, {"Citation": "Brannigan JA, Roberts SM, Bell AS, et al. Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors. IUCrJ. 2014;1:250\u2013260. doi: 10.1107/S2052252514013001.", "ArticleIdList": ["10.1107/S2052252514013001", "PMC4107925", "25075346"]}, {"Citation": "Chaudhary KK, Mishra N. A review on molecular docking: novel tool for drug discovery. JSM Chem. 2016;4:1029."}, {"Citation": "Chouni A, Pal A, Gopal PK, Paul S. GC-MS Analysis and Screening of Anti-Proliferative Potential of Methanolic Extract of Garcinia Cowa on Different Cancer Cell Lines. Pharmacogn J. 2021;13:347\u2013361. doi: 10.5530/pj.2021.13.45.", "ArticleIdList": ["10.5530/pj.2021.13.45"]}, {"Citation": "Corpas-Lopez V, Moniz S, Thomas M, et al. Pharmacological validation of n-myristoyltransferase as a drug target in Leishmania donovani. ACS Infect Dis. 2019;5:111\u2013122. doi: 10.1021/acsinfecdis.8b00226.", "ArticleIdList": ["10.1021/acsinfecdis.8b00226", "PMC6332449", "30380837"]}, {"Citation": "Cunningham ML, Fairlamb AH. Trypanothione reductase from Leishmania donovani purification, characterisation and inhibition by trivalent antimonials. Eur J Biochem. 1995;230:460\u2013468. doi: 10.1111/j.1432-1033.1995.tb20583.x.", "ArticleIdList": ["10.1111/j.1432-1033.1995.tb20583.x", "7607216"]}, {"Citation": "Dharavath S, Raj I, Gourinath S. Structure-based mutational studies of O-acetylserine sulfhydrylase reveal the reason for the loss of cysteine synthase complex formation in Brucella abortus. Biochem J. 2017;474:1221\u20131239. doi: 10.1042/BCJ20161062.", "ArticleIdList": ["10.1042/BCJ20161062", "28126739"]}, {"Citation": "Dumas C, Ouellette M, Tovar J, et al. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J. 1997;16:2590\u20132598. doi: 10.1093/emboj/16.10.2590.", "ArticleIdList": ["10.1093/emboj/16.10.2590", "PMC1169870", "9184206"]}, {"Citation": "Goncalves V, Brannigan JA, Thinon E, et al. A fluorescence-based assay for N-myristoyltransferase activity. Anal Biochem. 2012;421:342\u2013344. doi: 10.1016/j.ab.2011.10.013.", "ArticleIdList": ["10.1016/j.ab.2011.10.013", "PMC3863716", "22051857"]}, {"Citation": "Gschwend DA, Good AC, Kuntz ID. Molecular docking towards drug discovery. J Mol Recognit. 1996;9:175\u2013186. doi: 10.1002/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D.", "ArticleIdList": ["10.1002/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D", "8877811"]}, {"Citation": "Hunter WN, Bailey S, Habash J, et al. Active site of trypanothione reductase. A target for rational drug design. J Mol Biol. 1992;227:322\u2013333. doi: 10.1016/0022-2836(92)90701-K.", "ArticleIdList": ["10.1016/0022-2836(92)90701-K", "1522596"]}, {"Citation": "Hutton JA, Goncalves V, Brannigan JA, et al. Structure-based design of potent and selective leishmania N-myristoyltransferase inhibitors. J Med Chem. 2014;57:8664\u20138670. doi: 10.1021/jm5011397.", "ArticleIdList": ["10.1021/jm5011397", "PMC4211304", "25238611"]}, {"Citation": "Ibrahim SRM, Abdallah HM, Mohamed GA, et al. Volatile oil profile of some lamiaceous plants growing in Saudi Arabia and their biological activities. Zeitschrift Fur Naturforsch Sect C J Biosci. 2017;72:35\u201341. doi: 10.1515/znc-2015-0234.", "ArticleIdList": ["10.1515/znc-2015-0234", "27458662"]}, {"Citation": "Joseph GS, Jayaprakasha GK, Selvi AT, et al. Antiaflatoxigenic and antioxidant activities of garcinia extracts. Int J Food Microbiol. 2005;101:153\u2013160. doi: 10.1016/j.ijfoodmicro.2004.11.001.", "ArticleIdList": ["10.1016/j.ijfoodmicro.2004.11.001", "15862877"]}, {"Citation": "Kant V, Vijayakumar S, Sahoo GC, et al. In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS) J Biomol Struct Dyn. 2019;37:481\u2013492. doi: 10.1080/07391102.2018.1429315.", "ArticleIdList": ["10.1080/07391102.2018.1429315", "29415627"]}, {"Citation": "Kedzierski L. Leishmaniasis vaccine: Where are we today? J Glob Infect Dis. 2010;2:177. doi: 10.4103/0974-777x.62881.", "ArticleIdList": ["10.4103/0974-777x.62881", "PMC2889658", "20606974"]}, {"Citation": "Kureshi AA, Dholakiya C, Hussain T, et al. Simultaneous identification and quantification of three xanthones and two polyisoprenylated benzophenones in eight Indian Garcinia species using a validated UHPLC-PDA method. J AOAC Int. 2019;102:1423\u20131434. doi: 10.1093/jaoac/102.5.1423.", "ArticleIdList": ["10.1093/jaoac/102.5.1423", "30808434"]}, {"Citation": "Mazumder M, Gourinath S. Structure-based design of inhibitors of the crucial cysteine biosynthetic pathway enzyme O-acetyl serine sulfhydrylase. Curr Top Med Chem. 2015;16:948\u2013959. doi: 10.2174/1568026615666150825142422.", "ArticleIdList": ["10.2174/1568026615666150825142422", "26303427"]}, {"Citation": "Menon LN, Shameer PS, Sarma J, Rameshkumar KB. Profiles of volatile chemicals from the leaves of six Garcinia species from North East India. Nat Prod Res. 2019 doi: 10.1080/14786419.2019.1667349.", "ArticleIdList": ["10.1080/14786419.2019.1667349", "31542951"]}, {"Citation": "Mercado-Camargo J, Cervantes-Ceballos L, Vivas-Reyes R, et al. Homology modeling of Leishmanolysin (gp63) from Leishmania panamensis and molecular docking of flavonoids. ACS Omega. 2020;5:14741\u201314749. doi: 10.1021/acsomega.0c01584.", "ArticleIdList": ["10.1021/acsomega.0c01584", "PMC7315592", "32596611"]}, {"Citation": "Negi JS, Bisht VK, Singh P, et al. Naturally occurring xanthones: chemistry and biology. J Appl Chem. 2013 doi: 10.1155/2021/8725409.", "ArticleIdList": ["10.1155/2021/8725409"]}, {"Citation": "Olaleye TO, Brannigan JA, Roberts SM, et al. Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites. Org Biomol Chem. 2014;12:8132\u20138137. doi: 10.1039/c4ob01669f.", "ArticleIdList": ["10.1039/c4ob01669f", "PMC4224572", "25230674"]}, {"Citation": "Palsson B. The advent of high-throughput technologies. Nat Biotechnol. 2000;18:1147\u20131150. doi: 10.1038/81125.", "ArticleIdList": ["10.1038/81125", "11062431"]}, {"Citation": "Panethymitaki C, Bowyer PW, Price HP, et al. Characterization and selective inhibition of myristoyl-CoA: protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major. Biochem J. 2006;396:277\u2013285. doi: 10.1042/BJ20051886.", "ArticleIdList": ["10.1042/BJ20051886", "PMC1462705", "16480339"]}, {"Citation": "Payinachulli M, Marandi M, Attumulli T. Phytochemical and pharmacological potential of Acanthus ilicifolius. J Pharmacy Bioallied Sci. 2013;5:17\u201320. doi: 10.4103/0975-7406.106557.", "ArticleIdList": ["10.4103/0975-7406.106557", "PMC3612333", "23559819"]}, {"Citation": "Pinzi L, Rastelli G. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019 doi: 10.3390/ijms20184331.", "ArticleIdList": ["10.3390/ijms20184331", "PMC6769923", "31487867"]}, {"Citation": "Rackham MD, Yu Z, Brannigan JA, et al. Discovery of high-affinity inhibitors of Leishmania donovani N-myristoyltransferase. Medchemcomm. 2015;6:1761\u20131766. doi: 10.1039/c5md00241a.", "ArticleIdList": ["10.1039/c5md00241a", "PMC4757855", "26962429"]}, {"Citation": "Raj I, Kumar S, Gourinath S. The narrow active-site cleft of O-acetylserine sulfhydrylase from Leishmania donovani allows complex formation with serine acetyltransferases with a range of C-terminal sequences. Acta Crystallogr Sect D Biol Crystallogr. 2012;68:909\u2013919. doi: 10.1107/S0907444912016459.", "ArticleIdList": ["10.1107/S0907444912016459", "22868756"]}, {"Citation": "Rodrigues IA, Mazotto AM, Cardoso V, et al. Natural products: insights into leishmaniasis inflammatory response. Mediators Inflamm. 2015 doi: 10.1155/2015/835910.", "ArticleIdList": ["10.1155/2015/835910", "PMC4619978", "26538837"]}, {"Citation": "Rom\u00e3o PRT, Tovar J, Fonseca SG, et al. Glutathione and the redox control system trypanothione/trypanothione reductase are involved in the protection of Leishmania spp. against nitrosothiol-induced cytotoxicity. Braz J Med Biol Res. 2006;39:355\u2013363. doi: 10.1590/S0100-879X2006000300006.", "ArticleIdList": ["10.1590/S0100-879X2006000300006", "16501815"]}, {"Citation": "Saccoliti F, Angiulli G, Pupo G, et al. Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives. J Enzyme Inhib Med Chem. 2017;32:304\u2013310. doi: 10.1080/14756366.2016.1250755.", "ArticleIdList": ["10.1080/14756366.2016.1250755", "PMC6010130", "28098499"]}, {"Citation": "Shukla AK, Patra S, Dubey VK. Evaluation of selected antitumor agents as subversive substrate and a potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis. Mol Cell Biochem. 2011;352:261\u2013270. doi: 10.1007/s11010-011-0762-0.", "ArticleIdList": ["10.1007/s11010-011-0762-0", "21359528"]}, {"Citation": "Singh K, Singh KP, Equbal A, et al. Interaction between cysteine synthase and serine O-acetyltransferase proteins and their stage-specific expression in Leishmania donovani. Biochimie. 2016;131:29\u201344. doi: 10.1016/j.biochi.2016.09.004.", "ArticleIdList": ["10.1016/j.biochi.2016.09.004", "27638321"]}, {"Citation": "Spyrakis F, Singh R, Cozzini P, et al. Isozyme-specific ligands for O-acetylserine sulfhydrylase, a novel antibiotic target. PLoS ONE. 2013 doi: 10.1371/journal.pone.0077558.", "ArticleIdList": ["10.1371/journal.pone.0077558", "PMC3805590", "24167577"]}, {"Citation": "Tate EW, Bell AS, Rackham MD, Wright MH. N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis. Parasitology. 2014;141:37\u201349. doi: 10.1017/S0031182013000450.", "ArticleIdList": ["10.1017/S0031182013000450", "23611109"]}, {"Citation": "Terstappen GC, Reggiani A. In silico research in drug discovery. Trends Pharmacol Sci. 2001;22:23\u201326. doi: 10.1016/S0165-6147(00)01584-4.", "ArticleIdList": ["10.1016/S0165-6147(00)01584-4", "11165668"]}, {"Citation": "Tovar J, Cunningham ML, Smith AC, et al. Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homolog: effect on parasite intracellular survival. Proc Natl Acad Sci USA. 1998;95:5311\u20135316. doi: 10.1073/pnas.95.9.5311.", "ArticleIdList": ["10.1073/pnas.95.9.5311", "PMC20257", "9560272"]}, {"Citation": "Tovar J, Wilkinson S, Mottram JC, Fairlamb AH. Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus. Mol Microbiol. 1998;29:653\u2013660. doi: 10.1046/j.1365-2958.1998.00968.x.", "ArticleIdList": ["10.1046/j.1365-2958.1998.00968.x", "9720880"]}, {"Citation": "Turcano L, Torrente E, Missineo A, et al. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS Negl Trop Dis. 2018;12:1\u201321. doi: 10.1371/journal.pntd.0006969.", "ArticleIdList": ["10.1371/journal.pntd.0006969", "PMC6283646", "30475811"]}, {"Citation": "Wahyuni FS, Shaari K, Stanslas J, et al. Cytotoxic compounds from the leaves of Garcinia Cowa Roxb. J Appl Pharm Sci. 2015;5:6\u201311. doi: 10.7324/JAPS.2015.50202.", "ArticleIdList": ["10.7324/JAPS.2015.50202"]}, {"Citation": "Williams RAM, Westrop GD, Coombs GH. Two pathways for cysteine biosynthesis in Leishmania major. Biochem J. 2009;420:451\u2013462. doi: 10.1042/BJ20082441.", "ArticleIdList": ["10.1042/BJ20082441", "19296828"]}, {"Citation": "Wright MH, Paape D, Storck EM, et al. Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani. Chem Biol. 2015;22:342\u2013354. doi: 10.1016/j.chembiol.2015.01.003.", "ArticleIdList": ["10.1016/j.chembiol.2015.01.003", "PMC4372256", "25728269"]}, {"Citation": "Yu Y, Santat LA, Choi S. Bioinformatics packages for sequence analysis. Appl Mycol Biotechnol. 2006;6:143\u2013160. doi: 10.1016/S1874-5334(06)80009-2.", "ArticleIdList": ["10.1016/S1874-5334(06)80009-2"]}, {"Citation": "Zheljazkov VD, Cantrell CL, Tekwani B, Khan SI. Content, composition, and bioactivity of the essential oils of three basil genotypes as a function of harvesting. J Agric Food Chem. 2008;56:380\u2013385. doi: 10.1021/jf0725629.", "ArticleIdList": ["10.1021/jf0725629", "18095647"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "5", "Day": "12"}, {"Year": "2021", "Month": "8", "Day": "7"}, {"Year": "2022", "Month": "3", "Day": "18", "Hour": "5", "Minute": "13"}, {"Year": "2022", "Month": "3", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "19", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35299910", "PMC8901847", "10.1007/s12639-021-01441-7", "1441"]}}], "PubmedBookArticle": []}